Non-Invasive Markers for the Diagnosis of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, especially in patients with obesity. Here, Dr. Johanna Brix, a leading diabetologist and obesity specialist from Austria, delves into the critical role of non-invasive markers in diagnosing MASLD.
- Pre Questionnaire
- Video
- Post Questionnaire
EASO has received funding to support components of the 5-MIN CPD programme via an unrestricted grant from Boehringer-Ingelheim. Boehringer-Ingelheim had no influence over the content of any of the modules.